What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Endocrinology
Pharmacology, Eslicarbazepine acetate, Internal medicine, Endocrinology and Anticonvulsant are his primary areas of study.
The concepts of his Pharmacology study are interwoven with issues in Carbamazepine, Oxcarbazepine and Sodium channel.
His Eslicarbazepine acetate research includes elements of Anesthesia, Tolerability and Active metabolite.
Patrício Soares-da-Silva combines subjects such as Adverse effect, Randomized controlled trial, Surgery and Adjunctive treatment with his study of Anesthesia.
His study on Pharmacokinetics also encompasses disciplines like
- Dosing together with Cerebrospinal fluid,
- Licarbazepine that connect with fields like Metabolite.
His Dopamine research integrates issues from Receptor, Biochemistry, Homovanillic acid and Sodium.
His most cited work include:
- Pharmacokinetic and safety profile of trans‐resveratrol in a rising multiple‐dose study in healthy volunteers (287 citations)
- Mechanisms of Action of Carbamazepine and Its Derivatives, Oxcarbazepine, BIA 2-093, and BIA 2-024* (211 citations)
- Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide Derivatives (208 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Pharmacology, Dopamine and Eslicarbazepine acetate.
Internal medicine is closely attributed to Na+/K+-ATPase in his work.
His studies link Sodium with Endocrinology.
His research in Pharmacology intersects with topics in Levodopa, COMT inhibitor and Oxcarbazepine.
Patrício Soares-da-Silva interconnects Catecholamine, Receptor, Monoamine oxidase and 3,4-Dihydroxyphenylacetic acid in the investigation of issues within Dopamine.
His Eslicarbazepine acetate research is multidisciplinary, incorporating perspectives in Anesthesia and Tolerability, Adverse effect.
He most often published in these fields:
- Internal medicine (55.73%)
- Endocrinology (35.82%)
- Pharmacology (40.40%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (55.73%)
- Parkinson's disease (10.46%)
- Pharmacology (40.40%)
In recent papers he was focusing on the following fields of study:
Patrício Soares-da-Silva focuses on Internal medicine, Parkinson's disease, Pharmacology, Adverse effect and Levodopa.
His Internal medicine research incorporates themes from Endocrinology and Eslicarbazepine acetate.
Research on Epilepsy and Carbamazepine is a part of his Eslicarbazepine acetate study.
His study in the field of Pharmacokinetics is also linked to topics like BIA 10-2474.
His research integrates issues of Discontinuation, Clinical endpoint, Clinical trial and Incidence in his study of Adverse effect.
His Levodopa study combines topics from a wide range of disciplines, such as Anesthesia and Dyskinesia.
Between 2015 and 2021, his most popular works were:
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial (109 citations)
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial (109 citations)
- Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial (65 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Biochemistry
Patrício Soares-da-Silva mainly focuses on Internal medicine, Adverse effect, Levodopa, Eslicarbazepine acetate and Pharmacology.
His Internal medicine research incorporates elements of Endocrinology, Na+/K+-ATPase and Epithelial sodium channel.
His studies deal with areas such as Nausea, Clinical endpoint and Pharmacotherapy as well as Adverse effect.
His Levodopa study integrates concerns from other disciplines, such as Anesthesia and Dyskinesia.
His study in Eslicarbazepine acetate is interdisciplinary in nature, drawing from both Controlled release and Rash.
His Pharmacology research focuses on Pharmacokinetics in particular.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
